SANOFI-AVENTIS (EPA:SAN) | Finanzwire

Basculer en Français

10796	Companies
233363	Keywords
162043	Articles
124567	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 12/06/2024 at 07:30, 1 year 7 months ago

Press Release: Availability of the revised financial statements for Sanofi excluding Opella
Sanofi releases revised financial statements excluding Opella. The adjustments classify Opella as discontinued operations, aligning with Sanofi's transition to a biopharma company. Q4 2024 results expected on Jan 30, 2025

Sanofi Discontinued Operations Opella Revised Financial Statements Biopharma Company
PRESS RELEASE

published on 10/25/2024 at 07:30, 1 year 9 months ago

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance
BRIEF

published on 10/24/2024 at 14:05, 1 year 9 months ago

Positive Phase 3 Data for Dupixent in Chronic Spontaneous Urticaria Released

Dupixent Chronic Spontaneous Urticaria Phase 3 Data ACAAI Presentation Treatment Innovation
PRESS RELEASE

published on 10/24/2024 at 14:00, 1 year 9 months ago

Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI
Dupixent phase 3 data in chronic spontaneous urticaria presented at ACAAI shows reduced itch and hive activity, potential new treatment for CSU patients

Dupixent Chronic Spontaneous Urticaria ACAAI Phase 3 Data Targeted Treatment
BRIEF

published on 10/21/2024 at 07:35, 1 year 9 months ago

Sanofi and CD&R join forces to grow Opella

Financial Transaction Sanofi CD&R Opella Consumer Health
PRESS RELEASE

published on 10/21/2024 at 07:30, 1 year 9 months ago

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R partner to fuel Opella's ambitions in consumer healthcare as Sanofi transfers a 50% stake in Opella. Opella to become a standalone leader backed by Sanofi's strategic support and guidance

Partnership Sanofi CD&R Consumer Healthcare Opella
BRIEF

published on 10/15/2024 at 22:10, 1 year 9 months ago

Sanofi Reports Share and Voting Rights Data for September 2024

Voting Rights Investor Information Sanofi September 2024 Shares Data
PRESS RELEASE

published on 10/15/2024 at 22:05, 1 year 9 months ago

Sanofi: Information concerning the total number of voting rights and shares - September 2024
Sanofi reports total number of voting rights and shares as of September 30, 2024, in compliance with French commercial and stock market regulations

Voting Rights French Commercial Code Shares Sanofi Stock Market Authority
BRIEF

published on 10/11/2024 at 08:35, 1 year 9 months ago

Sanofi considers selling majority stake in Opella

Participations Health Sanofi CD&R Opella
PRESS RELEASE

published on 10/11/2024 at 08:30, 1 year 9 months ago

Press Release: Sanofi in discussions to sell a controlling stake in Opella
Sanofi is in discussions to sell a controlling stake in Opella, its consumer healthcare business, to CD&R. Opella aims for independence aligning with Sanofi’s focus on innovative medicines and vaccines

Negotiations Sale Sanofi Consumer Healthcare Opella

Accesswire

Published on 08/03/2026 at 23:00, 2 hours 45 minutes ago

Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/01/2026 at 01:20, 3 days ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 3 days ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 3 days 1 hour ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 3 days 1 hour ago

BioNxt Solutions Announces Option Grants

View all ACCESSWIRE

EQS Group

Published on 08/03/2026 at 23:33, 2 hours 12 minutes ago

EQS-Adhoc: Verbio SE: Preliminary EBITDA for FY 2025/2026 exceeds forecast
Published on 08/03/2026 at 23:20, 2 hours 25 minutes ago

DeFi Technologies Announces Shareholder Call to Discuss Q2 2026 Financial Results
Published on 08/03/2026 at 21:39, 4 hours 6 minutes ago

PAUL Tech AG reports net income after tax of EUR 3.2 million for fiscal year 2025 and issues a positive outlook for fiscal year 2026
Published on 08/03/2026 at 19:35, 6 hours 10 minutes ago

Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
Published on 08/03/2026 at 19:01, 6 hours 44 minutes ago

EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care reports operating income excluding special items to be above market expectations in Q2 2026 and confirms its outlook for the financial year 2026

Les Echos

Published on 08/03/2026 at 18:45, 7 hours ago

Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 18:00, 7 hours 45 minutes ago

H1 2026 revenue
Published on 08/03/2026 at 17:45, 8 hours ago

Monthly disclosure of the total number of shares and voting rights - July 2026
Published on 08/03/2026 at 17:45, 8 hours ago

Weekly share buyback
Published on 08/03/2026 at 17:40, 8 hours 5 minutes ago

Eiffage announces the end of exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany

View all LES ECHOS COMFI WIRE